Axelopran for Advanced Cancer in Patients Receiving Opioids

Clinical trial NCT07354919 · RECRUITING

Trial details

NCT number: NCT07354919
Sponsor: HealthPartners Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Lung Cancer Pancreas Cancer Prostate Cancer

Start date: 2026-04-27
Primary completion: 2027-11-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.